CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Pancreatic Biopsy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01677312
NCT01677312N/ACompleted
CompareCT.gov

Multi-Center Randomized Trial Comparing 19 and 25-gauge Needles for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) of Solid Pancreatic Mass Lesions

AdventHealth·interventional·Posted Sep 3, 2012·Updated Mar 17, 2020

In Brief

A clinical study evaluating Pancreatic Biopsy and Histological Samples for Cancer of Pancreas and Pancreatic Neoplasm. Completed, enrolled 72 participants across 2 sites.

Detailed Summary

This study compares the 19G and 25G needles for procuring tissue samples from the pancreas during Endoscopic Ultrasound (EUS) procedures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer of Pancreas, Pancreatic Neoplasm
CountriesUnited States
CollaboratorsUniversity of Alabama at Birmingham

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 3, 2012
Enrollment StartAug 1, 2012
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.8 years ago

Interventions

Pancreatic Biopsyprocedure

A FNA needle will be used to biopsy the pancreatic mass. The rates of diagnostic accuracy (%) will be assessed. Diagnostic accuracy is defined as the proportion of patients in whom a definitive diagnosis can be obtained within a predetermined number of FNA passes.

Histological Samplesprocedure

The proportion of patients (%) in whom a histological tissue can be obtained when performing a biopsy of the pancreas using a specific needle will be assessed.